Financial reports
10-K
2023 FY
Annual report
26 Mar 24
10-Q
2023 Q3
Quarterly report
7 Dec 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
7 Jun 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
22 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Apr 24
8-K
Virpax Pharmaceuticals Reports 2023 Year-End Results
26 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
18 Mar 24
8-K
Virpax Pharmaceuticals Announces Reverse Stock
1 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
29 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
13 Dec 23
8-K
Departure of Directors or Certain Officers
7 Dec 23
8-K
Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
17 Nov 23
8-K
Virpax Pharmaceuticals Announces Leadership Transition
17 Nov 23
8-K
Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
16 Nov 23
Registration and prospectus
S-1/A
IPO registration (amended)
26 Apr 24
S-1
IPO registration
18 Apr 24
S-8
Registration of securities for employees
5 Apr 24
S-8
Registration of securities for employees
22 Nov 22
S-3
Shelf registration
7 Oct 22
S-8
Registration of securities for employees
6 May 22
POS EX
Additional exhibits for listing
15 Sep 21
424B4
Prospectus supplement with pricing info
15 Sep 21
FWP
Free writing prospectus
10 Sep 21
S-1
IPO registration
9 Sep 21
Proxies
DEF 14A
Definitive proxy
7 Dec 23
PRE 14A
Preliminary proxy
21 Nov 23
DEFA14A
Additional proxy soliciting materials
22 Jun 23
DEF 14A
Definitive proxy
7 Jun 23
DEFA14A
Additional proxy soliciting materials
21 Jun 22
DEFA14A
Additional proxy soliciting materials
15 Jun 22
DEF 14A
Definitive proxy
15 Jun 22
Other
EFFECT
Notice of effectiveness
19 Oct 22
CORRESP
Correspondence with SEC
14 Oct 22
UPLOAD
Letter from SEC
13 Oct 22
EFFECT
Notice of effectiveness
15 Sep 21
CORRESP
Correspondence with SEC
9 Sep 21
CORRESP
Correspondence with SEC
9 Sep 21
UPLOAD
Letter from SEC
9 Sep 21
EFFECT
Notice of effectiveness
17 Feb 21
CERT
Certification of approval for exchange listing
16 Feb 21
SEC STAFF
SEC staff action: Order
16 Feb 21